Remove Chronic Disease Remove Complication Remove IT Remove Utilities
article thumbnail

Diabetes related complications among Ethiopian Jews-Outcomes of a 10 years cohort study in Israel [Population health and epidemiology]

Annals of Family Medicine

The context: Immigrants, particularly those moving from lower to higher-income countries, often exhibit a heightened susceptibility to non-communicable diseases, such as Type 2 diabetes (T2D), which may manifest at an earlier age and present with different complications compared to the native population. 0.83, HR 0.70; 95% CI 0.65-0.76,

article thumbnail

Using Machine Learning to advance primary care: an example of predictive modeling of hypertension risk to impact outcomes [Hypertension]

Annals of Family Medicine

Context: While hypertension is the most common chronic disease cared for during adult primary care visits, it is challenging to know which hypertensive patients have the highest risk of cardiovascular complications in the future.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top Challenges 2025: Practice administrators face growing uncertainty

Physician's Practice

The results also shed light on emerging concerns that could further complicate operations in 2025, including economic uncertainty and regulatory shifts. While some areas have shown modest improvement, many respondents report that key issues are becoming more difficult to manage, with optimism about the year ahead in short supply.

article thumbnail

Screening for Dementia: A Podcast with Anna Chodos, Joseph Gaugler and Soo Borson

GeriPal

Summary Transcript Summary The US Preventive Services Task Force (USPSTF) concluded back in 2000 that there is insufficient evidence to recommend for or against routine screening for dementia in older adults. Are there, though, populations that it may be helpful in, or should that change with the advent of the new amyloid antibodies? Should it?

Screening 119
article thumbnail

PC Trials at State of Science: Tom LeBlanc, Kate Courtright, & Corita Grudzen

GeriPal

I’m just stunned even writing that! We’ve come so far as a field. This isn’t to say we’ve “made it” – more to say that we’ve reached a new stage of maturation of the field – in which the evidence we are discussing is frequently high quality randomized trial level data. -@AlexSmithMD Transcript Eric: Welcome to the GeriPal podcast.